Recent Findings from Castle Biosciences Inc. Provides New Insights into Melanoma (The Integrated I31-gep Test Outperforms the Mskcc Nomogram At Predicting Sln Status In Melanoma Patients)

Press/Media

Period	29 Nov 2023

Media coverage

Title	Recent Findings from Castle Biosciences Inc. Provides New Insights into Melanoma (The Integrated I31-gep Test Outperforms the Mskcc Nomogram At Predicting Sln Status In Melanoma Patients)
Media name/outlet	Cancer Daily
Country/Territory	United States
Date	29/11/23
Persons	Michael Tassavor